<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Hetero &#8211; Generic Meds Mart</title>
	<atom:link href="https://genericmedsmart.com/brand/hetero/feed/" rel="self" type="application/rss+xml" />
	<link>https://genericmedsmart.com</link>
	<description>Smart choice for health. Affordable generic medicines.</description>
	<lastBuildDate>Fri, 19 Dec 2025 21:24:35 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.1</generator>

<image>
	<url>https://genericmedsmart.com/wp-content/uploads/2025/12/cropped-favicon-icon-logo-32x32.png</url>
	<title>Hetero &#8211; Generic Meds Mart</title>
	<link>https://genericmedsmart.com</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Hertab 250 mg Lapatinib (1 pack – 30 tabs)</title>
		<link>https://genericmedsmart.com/product/hertab-250-mg-lapatinib-30-tabs/</link>
					<comments>https://genericmedsmart.com/product/hertab-250-mg-lapatinib-30-tabs/#respond</comments>
		
		<dc:creator><![CDATA[gmm_wpuser]]></dc:creator>
		<pubDate>Mon, 17 Nov 2025 03:28:20 +0000</pubDate>
				<guid isPermaLink="false">http://localhost/wp-drugstore-test1/?post_type=product&#038;p=541</guid>

					<description><![CDATA[Hertab 250 mg contains lapatinib, an oral targeted therapy used under oncology supervision for HER2-positive advanced or metastatic breast cancer in appropriate regimens. Generic Meds Mart supplies Hertab 250 mg (1 pack / 30 tabs) in original packaging with secure checkout and worldwide delivery.]]></description>
										<content:encoded><![CDATA[<h1>Buy Hertab 250 mg Lapatinib Tablets Online</h1>
<h3><strong>Hertab 250 mg Lapatinib Tablets (1 pack / 30 tabs)</strong></h3>
<h3>At a Glance</h3>
<p><strong>Generic Name:</strong> <strong>Lapatinib</strong></p>
<p><strong>Brand Name:</strong> <strong>Hertab</strong></p>
<p><strong>Strength &amp; Pack Size:</strong> 250 mg <strong>lapatinib</strong> per tablet; 1 pack / 30 tablets</p>
<p><strong>Dosage Form &amp; Route:</strong> Oral tablet, swallowed whole with water</p>
<p><strong>Therapeutic Class:</strong> Tyrosine kinase inhibitor (EGFR/HER2 inhibitor), targeted anticancer therapy</p>
<p><strong>Primary Indication:</strong> <strong>HER2-positive breast cancer</strong> in appropriate regimens</p>
<p><strong>Usual Adult Dose:</strong> Total daily dose is commonly taken once daily as multiple 250 mg tablets, but the exact regimen is defined by your oncologist</p>
<p><strong>Prescription Status:</strong> Prescription-only medicine</p>
<p><strong>Storage:</strong> Store below 25–30 °C in original packaging, protect from moisture and light, keep out of reach of children</p>
<h2>Product Description</h2>
<p><strong>Hertab 250 mg</strong> contains <strong>lapatinib</strong>, an oral targeted anticancer medicine used in adults with <strong>HER2-positive breast cancer</strong> when your oncology team determines it is appropriate. This product is supplied as 250 mg tablets in a 1 pack / 30 tabs presentation, designed to support planned therapy and structured monitoring. <strong>Lapatinib</strong> is not a general-purpose medicine and should only be used within a confirmed diagnosis and a specialist-led treatment plan.</p>
<p>In <strong>HER2-positive breast cancer</strong>, treatment decisions are individualized and may depend on whether the disease is advanced or metastatic, what therapies have been used before, and how the cancer is behaving on scans and laboratory assessments. <strong>Lapatinib</strong> is often used in combination regimens rather than as a stand-alone treatment, and your oncologist will explain the role of the medicine, the expected goals, and the monitoring schedule. Do not start, stop, or change the way you take <strong>Hertab 250 mg</strong> without medical supervision, and do not rely on general online information to replace a personalised oncology plan.</p>
<p><strong>Generic Meds Mart</strong> supplies <strong>Hertab 250 mg lapatinib</strong> tablets in original manufacturer packaging sourced through licensed channels. The outer carton and blisters typically show the brand name, strength, active ingredient, batch number, and expiry date so your clinic or pharmacy can verify the product on receipt. Orders are packed in <strong>discreet</strong> outer parcels to support privacy, and delivery options are designed for <strong>international</strong> customers. If you are comparing options, confirm the correct strength and pack size with your care team before ordering and avoid making decisions based only on <strong>lapatinib price</strong>.</p>
<h2>Key Uses</h2>
<p><strong>Hertab 250 mg lapatinib</strong> is used in <strong>HER2-positive breast cancer</strong> when inhibition of HER2-driven signalling is clinically appropriate and the patient’s overall treatment plan supports an oral targeted option. In advanced or metastatic settings, <strong>lapatinib</strong> may be used as part of a combination regimen selected by an oncologist, especially when a structured oral schedule is helpful for ongoing treatment coordination and monitoring.</p>
<p>Your oncology team will define whether <strong>lapatinib</strong> is being used alongside another anticancer medicine, how response will be assessed, and what symptoms or lab changes should trigger contact with the clinic. Because targeted therapy still carries meaningful risks, <strong>lapatinib</strong> treatment is typically paired with monitoring for side effects, interactions, and adherence to the planned schedule. Always follow your specialist’s instructions, and if you need to <strong>order lapatinib online</strong>, do so only after your regimen and follow-up plan are clearly confirmed.</p>
<h2>How Lapatinib Works in Chemotherapy</h2>
<p><strong>Lapatinib</strong> works by inhibiting specific tyrosine kinases linked to tumour growth signals, particularly HER2 (ErbB2) and, in many cases, EGFR (ErbB1). In <strong>HER2-positive breast cancer</strong>, overactive HER2 signalling can drive uncontrolled cell growth and survival pathways. By blocking the intracellular kinase activity, <strong>lapatinib</strong> reduces downstream signalling that cancer cells use to proliferate and resist cell death, which can contribute to disease control when taken consistently within the prescribed regimen.</p>
<p>Because this mechanism is targeted signal inhibition rather than traditional DNA-damaging chemotherapy, <strong>lapatinib</strong> has a side-effect profile that differs from many classic cytotoxic agents. However, monitoring remains essential, and treatment may require supportive care, dose adjustments, or temporary interruption depending on tolerability. Your oncologist balances expected benefit with safety considerations such as gastrointestinal effects, liver function changes, and potential cardiac effects in susceptible patients.</p>
<h2>Dosage &amp; Administration</h2>
<p><strong>Hertab 250 mg</strong> tablets are taken by mouth exactly as prescribed by your oncologist. <strong>Lapatinib</strong> is commonly taken once daily as a total dose made up of multiple 250 mg tablets, and it may be scheduled in combination with other anticancer medicines depending on the protocol. Swallow tablets whole with water and do not crush or split them unless your clinic provides a specific instruction. Try to take the medicine at the same time each day to support consistent exposure and reliable monitoring.</p>
<p>Drug interactions can be clinically important with <strong>lapatinib</strong>. Some medicines can increase or decrease <strong>lapatinib</strong> levels in the body, including certain antibiotics, antifungals, anticonvulsants, and herbal products such as St John’s wort. Always share a complete list of prescription medicines, over-the-counter products, and supplements with your oncology team and pharmacist. Never self-adjust dosing, and if a dose is missed, follow your clinic’s guidance rather than taking extra tablets to “catch up.”</p>
<h2>Precautions</h2>
<p><strong>Lapatinib</strong> can cause diarrhoea and dehydration, which may become serious if not managed early. Your oncology team may provide a plan for anti-diarrhoeal treatment, hydration, and when to contact the clinic. Liver function changes can occur, so scheduled blood tests are important even if you feel well. Report symptoms such as yellowing of the skin or eyes, dark urine, severe fatigue, or persistent abdominal pain promptly.</p>
<p>Cardiac effects such as reduced left ventricular ejection fraction can occur in some patients, particularly those with existing heart disease or other risk factors, so your oncologist may arrange baseline and follow-up heart monitoring when appropriate. Lung toxicity is uncommon but can be serious, so new or worsening shortness of breath, cough, or fever should be assessed urgently. <strong>Lapatinib</strong> may harm an unborn baby, so effective contraception is required during treatment, and pregnancy planning must be discussed with your specialist.</p>
<h2>Lapatinib Side Effects</h2>
<h3>Common side effects</h3>
<p>Common <strong>lapatinib side effects</strong> may include diarrhoea, nausea, vomiting, reduced appetite, abdominal discomfort, fatigue, headache, mouth soreness, and skin changes such as rash or dryness. Some patients notice soreness of hands or feet when <strong>lapatinib</strong> is combined with other agents, and blood tests may show liver enzyme changes that require monitoring. Many side effects can be managed with supportive care when reported early, but you should not change the dose on your own.</p>
<h3>Serious side effects</h3>
<p>Serious side effects require urgent medical attention and may include severe or persistent diarrhoea with dehydration, significant liver injury, new or worsening shortness of breath, chest pain, fainting, or signs of a clinically important heart problem. Severe skin reactions are rare but can occur, especially if accompanied by fever, blistering, or widespread pain. If you experience alarming symptoms, seek urgent medical care and tell clinicians you are taking <strong>lapatinib</strong>.</p>
<h2>Storage</h2>
<p>Store <strong>Hertab 250 mg</strong> tablets below 25–30 °C, protected from moisture and direct light, and keep them in the original blister packaging until use to reduce mix-ups and maintain stability. Keep all medicines out of reach of children and pets. Do not use tablets after the expiry date printed on the carton or blisters, and follow pharmacist guidance for safe disposal of unused or expired tablets.</p>
<h2>Why Buy from Generic Meds Mart</h2>
<p><strong>Generic Meds Mart</strong> supports access and logistics for specialty oncology medicines such as <strong>Hertab 250 mg lapatinib</strong> tablets. Products are supplied in original packaging sourced through licensed channels, with batch and expiry details visible to support verification by pharmacies and oncology teams. Pricing is shown in <strong>USD</strong> and orders are processed through <strong>secure checkout</strong> designed for international customers.</p>
<p>Shipments are packed in <strong>discreet</strong> outer packaging to support privacy and reduce unwanted attention to sensitive treatment needs. We do not replace your treating doctor or provide personalised medical decisions. Whether <strong>lapatinib</strong> is appropriate, how it should be combined with other medicines, and how side effects are managed must be determined by qualified oncology professionals.</p>
<h2>Order Now</h2>
<p>Before you <strong>buy Hertab 250 mg online</strong> from <strong>Generic Meds Mart</strong>, you should have a confirmed <strong>HER2-positive breast cancer</strong> diagnosis and a treatment plan agreed with your oncologist. Your care team will define the correct total daily dose, timing, combination regimen (if used), and the monitoring schedule for side effects and response. Once your plan is confirmed, select <strong>Hertab 250 mg (1 pack / 30 tabs)</strong>, add it to your cart, and complete <strong>secure checkout</strong> in <strong>USD</strong>.</p>
<p>Do not start therapy on your own and do not stop or change dosing without medical guidance. If you develop severe diarrhoea, signs of liver problems, breathing difficulties, or symptoms that may suggest a heart issue, seek urgent medical care and inform clinicians that you are taking <strong>lapatinib</strong>.</p>
<h2><strong>FAQ</strong> about Hertab (Lapatinib)</h2>
<p><strong>Q1:</strong> What is Hertab 250 mg used for?</p>
<p><strong>Hertab 250 mg</strong> contains <strong>lapatinib</strong>, an oral targeted medicine used in <strong>HER2-positive breast cancer</strong> when prescribed by an oncologist as part of an appropriate regimen and monitoring plan.</p>
<p><strong>Q2:</strong> Is Hertab taken alone or with other medicines?</p>
<p><strong>Lapatinib</strong> is often used in combination regimens in advanced or metastatic breast cancer, and your oncologist will explain which medicines are combined and why that approach fits your situation.</p>
<p><strong>Q3:</strong> How do I take Hertab 250 mg tablets?</p>
<p><strong>Hertab</strong> tablets are taken by mouth on the schedule prescribed by your oncologist, commonly once daily as multiple 250 mg tablets to reach the planned total dose. Swallow tablets whole with water and follow your clinic’s timing instructions.</p>
<p><strong>Q4:</strong> What should I do if I get diarrhoea while taking lapatinib?</p>
<p>Diarrhoea can become serious, so contact your oncology team early for guidance on anti-diarrhoeal treatment, hydration, and when you need assessment. Do not self-adjust the dose without specialist advice.</p>
<p><strong>Q5:</strong> What monitoring is usually needed during treatment?</p>
<p>Monitoring commonly includes clinical checks and blood tests, especially liver function, and sometimes heart monitoring depending on your risk factors and the full treatment regimen. Your oncologist will set the schedule.</p>
]]></content:encoded>
					
					<wfw:commentRss>https://genericmedsmart.com/product/hertab-250-mg-lapatinib-30-tabs/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
